James Schultz

Array ( [id] => 7356592 [patent_doc_number] => 20040049022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Composition & methods for treatment and screening' [patent_app_type] => new [patent_app_number] => 10/627930 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41161 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20040049022.pdf [firstpage_image] =>[orig_patent_app_number] => 10627930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 536975 [patent_doc_number] => 07176302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-13 [patent_title] => 'Liposomal phosphodiester, phosphorothioate, and p-ethoxy oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/462172 [patent_app_country] => US [patent_app_date] => 2003-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 4196 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/176/07176302.pdf [firstpage_image] =>[orig_patent_app_number] => 10462172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7369504 [patent_doc_number] => 20040016006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Chromosome 3p21.3 genes are tumor suppressors' [patent_app_type] => new [patent_app_number] => 10/445718 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 48895 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20040016006.pdf [firstpage_image] =>[orig_patent_app_number] => 10445718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796919 [patent_doc_number] => 20030175793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Antisense modulation of NF-kappa-B p65 subunit expression' [patent_app_type] => new [patent_app_number] => 10/424211 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22881 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175793.pdf [firstpage_image] =>[orig_patent_app_number] => 10424211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7465902 [patent_doc_number] => 20040198640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Stabilized polynucleotides for use in RNA interference' [patent_app_type] => new [patent_app_number] => 10/406908 [patent_app_country] => US [patent_app_date] => 2003-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 17664 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198640.pdf [firstpage_image] =>[orig_patent_app_number] => 10406908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822126 [patent_doc_number] => 20030220287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Antisense nucleic acids' [patent_app_type] => new [patent_app_number] => 10/402099 [patent_app_country] => US [patent_app_date] => 2003-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11877 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220287.pdf [firstpage_image] =>[orig_patent_app_number] => 10402099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467881 [patent_doc_number] => 20040053876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'siRNAs and uses therof' [patent_app_type] => new [patent_app_number] => 10/397943 [patent_app_country] => US [patent_app_date] => 2003-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 41919 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053876.pdf [firstpage_image] =>[orig_patent_app_number] => 10397943 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7672935 [patent_doc_number] => 20040180844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Method of killing cancer cells' [patent_app_type] => new [patent_app_number] => 10/385163 [patent_app_country] => US [patent_app_date] => 2003-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10205 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180844.pdf [firstpage_image] =>[orig_patent_app_number] => 10385163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7143639 [patent_doc_number] => 20050118564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Methods and compositions for identification and therapeutic use of genes involved in vascular and proliferative diseases' [patent_app_type] => utility [patent_app_number] => 10/500769 [patent_app_country] => US [patent_app_date] => 2003-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10164 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118564.pdf [firstpage_image] =>[orig_patent_app_number] => 10500769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843642 [patent_doc_number] => 20030148989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Oligonucleotide inhibition of protein kinase C' [patent_app_type] => new [patent_app_number] => 10/348485 [patent_app_country] => US [patent_app_date] => 2003-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13420 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148989.pdf [firstpage_image] =>[orig_patent_app_number] => 10348485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6418300 [patent_doc_number] => 20100167377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Recombinant viruses comprising the membrane-proximal domain of VSV G protein' [patent_app_type] => utility [patent_app_number] => 10/327673 [patent_app_country] => US [patent_app_date] => 2002-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16625 [patent_no_of_claims] => 157 [patent_no_of_ind_claims] => 32 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20100167377.pdf [firstpage_image] =>[orig_patent_app_number] => 10327673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289161 [patent_doc_number] => 20040110151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of sentrin-2 expression' [patent_app_type] => new [patent_app_number] => 10/316638 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19483 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110151.pdf [firstpage_image] =>[orig_patent_app_number] => 10316638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289197 [patent_doc_number] => 20040110160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of SEDL expression' [patent_app_type] => new [patent_app_number] => 10/317280 [patent_app_country] => US [patent_app_date] => 2002-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20034 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110160.pdf [firstpage_image] =>[orig_patent_app_number] => 10317280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289155 [patent_doc_number] => 20040110147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Modulation of BAF53 expression' [patent_app_type] => new [patent_app_number] => 10/316243 [patent_app_country] => US [patent_app_date] => 2002-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20788 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110147.pdf [firstpage_image] =>[orig_patent_app_number] => 10316243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469069 [patent_doc_number] => 20040102397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of PPM1B expression' [patent_app_type] => new [patent_app_number] => 10/303328 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19525 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102397.pdf [firstpage_image] =>[orig_patent_app_number] => 10303328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469117 [patent_doc_number] => 20040102402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of tissue factor expression' [patent_app_type] => new [patent_app_number] => 10/304098 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22142 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102402.pdf [firstpage_image] =>[orig_patent_app_number] => 10304098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469010 [patent_doc_number] => 20040102390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Modulation of Notch3 expression' [patent_app_type] => new [patent_app_number] => 10/301832 [patent_app_country] => US [patent_app_date] => 2002-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19871 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102390.pdf [firstpage_image] =>[orig_patent_app_number] => 10301832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474205 [patent_doc_number] => 20040097452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of kallikrein 6 expression' [patent_app_type] => new [patent_app_number] => 10/300820 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20359 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097452.pdf [firstpage_image] =>[orig_patent_app_number] => 10300820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474186 [patent_doc_number] => 20040097449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of KIAA0415 expression' [patent_app_type] => new [patent_app_number] => 10/300288 [patent_app_country] => US [patent_app_date] => 2002-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19438 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097449.pdf [firstpage_image] =>[orig_patent_app_number] => 10300288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474162 [patent_doc_number] => 20040097445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Modulation of translation initiation factor IF2 expression' [patent_app_type] => new [patent_app_number] => 10/298955 [patent_app_country] => US [patent_app_date] => 2002-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20467 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097445.pdf [firstpage_image] =>[orig_patent_app_number] => 10298955 [rel_patent_id] =>[rel_patent_doc_number] =>)